Decoy Therapeutics is trading at $4.35 (-13.69%) in pre-market sessions as the stock extends a multi-day slide despite a lack of fresh fundamental news.
- No company-specific press releases, SEC filings, earnings updates, or analyst actions have been identified to explain the sharp overnight drop.
- The move follows a period of sustained weakness in previous trading sessions, significantly underperforming a broader risk-on market backdrop.
- The current decline represents an extension of a multi-day downward trend for the equity.